Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update MORRISVILLE, N.C., November 3, 2025 – Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced its financial results for the third quarter ended September 30, 2025. The company will also host a webcast at 8:30 a.m. Eastern Time on November 3, 2025, to review financial per ...